SciELO - Scientific Electronic Library Online

 
vol.41 número1Intervalos biológicos de referencia del perfil lipídicoTiempo en rango terapéutico (TRT) en clínica de anticoagulación. Reportes de eventos adversos y factores asociados a bajo TRT índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

  • En proceso de indezaciónCitado por Google
  • No hay articulos similaresSimilares en SciELO
  • En proceso de indezaciónSimilares en Google

Compartir


Acta Medica Colombiana

versión impresa ISSN 0120-2448

Resumen

MORA, Gloria Elena et al. Clinical characterization of patients with myelodysplastic syndrome. Acta Med Colomb [online]. 2016, vol.41, n.1, pp.36-41. ISSN 0120-2448.

Objective:

to describe the clinical and socio-demographic characteristics and quality of life of patients with myelodysplastic syndrome (MDS).

Design:

a descriptive cross-sectional study.

Framework:

Hospital San José de Bogota (fourth level institution).

Population:

thirty-nine patients diagnosed with MDS, older than 18 years, obtained in the statistics department.

Main measurements:

frequency of clinical and sociodemographic variables and quality of life measured by FACT-G scale.

Results:

the mean age was 74 years, with male predominance. The most frequent diagnosis was type mutilineage MDS dysplasia, and the most prevalent cytopenia was anemia. Most patients were classified as very low risk or low risk by IPSS-R and WPSS scale and low-risk and intermediate risk -1by IPSS and MDACC scale. Progression to acute myeloid leukemia occurred in 7.69%, while mortality occurred in 15.38%. There was a higher incidence of death and transformation to leukemia in patients classified as high risk. The quality of life was lower in patients with anemia and was higher in the MDS-(del5q).

Conclusions:

The characteristics of the study population are similar to those reported in the literature (predominantly in men, subtype of MDS more frequent, predominant cytopenia and risk distribution). There were differences with respect to age, frequency of comorbidities and their relationship to mortality. Quality of life was correlated with the subtype of MDS and cytopenias. (Acta Med Colomb 2016; 41: 36-41).

Palabras clave : myelodysplastic syndrome; quality of life; study of bone marrow; erythropoietin; azacytidine.

        · resumen en Español     · texto en Español     · Español ( pdf )